AREX specializes in delivering high-quality, bioactive recombinant proteins designed to accelerate breakthroughs in life science research and therapeutic development. Our portfolio encompasses a diverse range of proteins, including human, mouse, other mammalian, and viral proteins, all engineered with precision to retain native structure and functionality.
Read more about
Product List
Structure Meets Function
The efficacy of AREX recombinant proteins lies in their ability to mimic natural biomolecular interactions. Like antibodies that target specific antigens through paratope-epitope binding, our proteins are engineered with functional domains that enable precise binding to cellular targets, receptors, or ligands. This molecular accuracy ensures reliable performance in: ·Protein-protein interaction studies (e.g., ELISA, SPR, co-IP) ·Biochemical and cell-based assays (e.g., enzyme activity, receptor activation) ·Diagnostic reagent development (e.g., biomarker detection, assay standards) ·Drug discovery pipelines (e.g., target validation, therapeutic screening)
Versatility for Complex Challenges
AREX proteins are rigorously validated for purity, stability, and bioactivity, empowering researchers to tackle diverse challenges—from elucidating disease mechanisms to designing targeted therapies. Whether blocking viral entry, modulating immune responses, or enabling structural studies, our recombinant proteins serve as indispensable tools in advancing science and medicine.
Tailored Solutions for Global Impact
At AREX, we prioritize customization and scalability. Our team collaborates closely with clients to deliver proteins tailored to unique experimental needs, accelerating timelines for diagnostics, therapeutics, and beyond. Explore the precision of AREX recombinant proteins—where innovation meets reliability to redefine biomedical possibilities.